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Background and objectives:  
Lignans are phenolic compounds found in olive oil, whole grains and seeds, among others. A 
healthy lifestyle and a healthy diet can reduce the risk of chronic diseases, which are a worldwide 
burden.  
The objective was to prospectively evaluate the association between lignan intake and the incidence 
of chronic diseases within the PREDIMED study (ISRCTN 35739639), which includes 7,447 
participants at high cardiovascular risk that were followed a median of 4,8 years. 
Methodology:  
Dietary intake of lignans was obtained from yearly food frequency questionnaires using the Phenol-
explorer database. Time-dependent Cox proportional hazard models were used to estimate hazard 
ratios (HR) and 95% confidence intervals (CI) for chronic diseases and mortality according to 
lignan intake. Statistical analyses were conducted by using SAS software, version 9.3. 
Results and conclusions:  
After multivariate adjustment and comparing the highest versus the lowest categories, lignan intake 
was inversely associated with cardiovascular events (HR=0.51, 95% CI 0.30-0.86, P-lineal=0.007), 
incidence of type 2 diabetes (HR=0.71, 95% CI 0.51-0.98, P-lineal=0.05), and all cause mortality 
(HR=0.60, 95% CI 0.37-0.97, P-lineal=0.03). In this population, olive oil was the main source of 
lignans (72%). 
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